Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Testing effectiveness (Phase 2)UnknownNCT00270543What this trial is testingAn Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric CancerWho this might be right forStomach Neoplasms Far Eastern Memorial Hospital 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872What this trial is testingStudy of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsWho this might be right forSolid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more Cybrexa Therapeutics 130
Testing effectiveness (Phase 2)Study completedNCT02689284What this trial is testingCombination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction CancerWho this might be right forGastric CancerStomach CancerEsophageal Cancer MacroGenics 95
Testing effectiveness (Phase 2)Study completedNCT00511446What this trial is testingTrial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric CancerWho this might be right forStomach Neoplasms Martin-Luther-Universität Halle-Wittenberg 56
Not applicableLooking for participantsNCT06846996What this trial is testingReal-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in ChinaWho this might be right forHER2-positive Gastric CancerHER2-positive Gastroesophageal Junction Daiichi Sankyo 260
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Large-scale testing (Phase 3)UnknownNCT04714190What this trial is testingRC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-OverexpressionWho this might be right forGastric CancerHER2 Overexpressing Gastric Carcinoma RemeGen Co., Ltd. 351
Early research (Phase 1)Looking for participantsNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)Study completedNCT05535569What this trial is testingPhase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric CancerWho this might be right forRecurrent/Metastatic Gastric Cancer Yonsei University 50
Testing effectiveness (Phase 2)UnknownNCT05095636What this trial is testingApatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric CancerWho this might be right forGastric CancerMetastasis Fudan University 102
Large-scale testing (Phase 3)Looking for participantsNCT06346197What this trial is testingCombination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric AdenocarcinomasWho this might be right forGastric CancerMSI-HMetastatic Cancer+1 more Centre Leon Berard 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116136What this trial is testingEvaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.Who this might be right forMSI-H/dMMR Gastroesophageal-junction CancerMSI-H/dMMR Gastric Cancer Servier Bio-Innovation LLC 38
Testing effectiveness (Phase 2)UnknownNCT01305993What this trial is testingEvaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric CancerWho this might be right forGastric Cancer SBPharmaceutical IND, Co., LTD 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04847466What this trial is testingImmunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck CancerWho this might be right forGastroesophageal Junction (GEJ) CancersAdvanced HNSCC National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Early research (Phase 1)Looking for participantsNCT07066657What this trial is testingMRG007 (ARR-217) in Patients With Advanced Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid TumorsColorectal CancerGastric Cancer+1 more ArriVent BioPharma, Inc. 405
Testing effectiveness (Phase 2)Study completedNCT01611857What this trial is testingPhase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or StomachWho this might be right forMalignant Solid TumourGastroesophageal Cancer SCRI Development Innovations, LLC 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639219What this trial is testingT-DXd for the Treatment of Solid Tumors Harboring HER2 Activating MutationsWho this might be right forAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast AstraZeneca 102
Early research (Phase 1)Study completedNCT03330561What this trial is testingPRS-343 in HER2-Positive Solid TumorsWho this might be right forHER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Bladder Cancer+1 more Pieris Pharmaceuticals, Inc. 85